CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway
Abstract Background Chemokine (C-C motif) ligand 18 (CCL18) affects the malignant progression of varying cancers by activating chemokine receptors. Our previous work has shown that CCL18 promotes hyperplasia and invasiveness of oral cancer cells; however, the cognate receptors of CCL18 involved in t...
Main Authors: | Xiao Jiang, Zhijie Huang, Xiang Sun, Xianghuai Zheng, Jingpeng Liu, Jun Shen, Bo Jia, Haiyun Luo, Zhaoyi Mai, Guodong Chen, Jianjiang Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-020-07073-z |
Similar Items
-
JAK/STAT in leukemia: a clinical update
by: Dong Liang, et al.
Published: (2024-01-01) -
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
by: Maddison Lensing, et al.
Published: (2022-08-01) -
JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases
by: Mariely A. Godoi, et al.
Published: (2023-06-01) -
Leptin-Induced JAK/STAT Signaling and Cancer Growth
by: McKay Mullen, et al.
Published: (2016-07-01) -
C-C Motif Chemokine Ligand 5 (CCL5) Promotes Irradiation-Evoked Osteoclastogenesis
by: Jing Wang, et al.
Published: (2023-11-01)